Broderick Brian C Novartis Ag Transaction History

Broderick Brian C

$430 Million
Q1 2024

A detailed history of Broderick Brian C transactions in Novartis Ag stock. As of the latest transaction made, Broderick Brian C holds 21,834 shares of NVS stock, worth $2.4 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

21,834

Previous 27,960 21.91%

Holding current value

$2.4 Million

Previous $2.82 Million 25.19%

% of portfolio

0.49%

Previous 0.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$95.27 - $108.47 $583,624 - $664,487	-6,126 Reduced 21.91%	21,834 $2.11 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $97,344 - $107,124	-1,055 Reduced 3.64%	27,960 $2.82 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $134,990 - $149,810	1,425 Added 5.16%	29,015 $2.96 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $33,307 - $37,767	-360 Reduced 1.29%	27,590 $2.78 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $42,015 - $48,725	-525 Reduced 1.84%	27,950 $2.57 Million

Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $145,811 - $178,563	-1,930 Reduced 6.35%	28,475 $2.58 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $147,727 - $172,774	-1,980 Reduced 6.11%	30,405 $2.31 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $309,840 - $360,750	-3,848 Reduced 10.62%	32,385 $2.74 Million
Q1 2022 May 17, 2022	SELL	$80.11 - $90.62 $389,895 - $441,047	-4,867 Reduced 11.84%	36,233 $3.18 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $2.18 Million - $2.41 Million	-27,295 Reduced 39.91%	41,100 $3.6 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $990,274 - $1.15 Million	-12,109 Reduced 15.04%	68,395 $5.59 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $415,033 - $458,416	-4,869 Reduced 5.7%	80,504 $7.34 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $70,724 - $83,404	-847 Reduced 0.98%	85,373 $7.3 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $33,179 - $40,132	-425 Reduced 0.49%	86,220 $8.14 Million
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $77,293 - $85,631	941 Added 1.1%	86,645 $7.54 Million
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $55,275 - $62,221	-683 Reduced 0.79%	85,704 $7.49 Million
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $14,982 - $20,990	212 Added 0.25%	86,387 $7.12 Million
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $52,887 - $59,796	-627 Reduced 0.72%	86,175 $8.16 Million
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $56,713 - $62,494	-663 Reduced 0.76%	86,802 $7.54 Million
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $9,802 - $12,064	-130 Reduced 0.15%	87,465 $7.99 Million
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $115,390 - $131,981	-1,532 Reduced 1.72%	87,595 $8.42 Million
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $176,931 - $197,012	-2,402 Reduced 2.62%	89,127 $7.65 Million
Q3 2018 Oct 15, 2018	BUY	$66.94 - $77.43 $17,538 - $20,286	262 Added 0.29%	91,529 $7.89 Million
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $66,208 - $74,827	1,020 Added 1.13%	91,267 $6.89 Million
Q1 2018 Apr 24, 2018	BUY	$70.39 - $84.15 $2,956 - $3,534	42 Added 0.05%	90,247 $7.3 Million
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $291,634 - $313,044	-4,032 Reduced 4.28%	90,205 $7.57 Million
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $6.99 Million - $7.28 Million	94,237	94,237 $8.09 Million

Others Institutions Holding NVS

# of Institutions

1,352

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $236B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Novartis Ag Transaction History